A subscription to JoVE is required to view this content. Sign in or start your free trial.
Here, we describe a method for in vivo microdialysis to analyze aspartate and glutamate release in the ventral hippocampus of epileptic and non-epileptic rats, in combination with EEG recordings. Extracellular concentrations of aspartate and glutamate may be correlated with the different phases of the disease.
Microdialysis is a well-established neuroscience technique that correlates the changes of neurologically active substances diffusing into the brain interstitial space with the behavior and/or with the specific outcome of a pathology (e.g., seizures for epilepsy). When studying epilepsy, the microdialysis technique is often combined with short-term or even long-term video-electroencephalography (EEG) monitoring to assess spontaneous seizure frequency, severity, progression and clustering. The combined microdialysis-EEG is based on the use of several methods and instruments. Here, we performed in vivo microdialysis and continuous video-EEG recording to monitor glutamate and aspartate outflow over time, in different phases of the natural history of epilepsy in a rat model. This combined approach allows the pairing of changes in the neurotransmitter release with specific stages of the disease development and progression. The amino acid concentration in the dialysate was determined by liquid chromatography. Here, we describe the methods and outline the principal precautionary measures one should take during in vivo microdialysis-EEG, with particular attention to the stereotaxic surgery, basal and high potassium stimulation during microdialysis, depth electrode EEG recording and high-performance liquid chromatography analysis of aspartate and glutamate in the dialysate. This approach may be adapted to test a variety of drug or disease induced changes of the physiological concentrations of aspartate and glutamate in the brain. Depending on the availability of an appropriate analytical assay, it may be further used to test different soluble molecules when employing EEG recording at the same time.
To provide insight into the functional impairment of glutamate-mediated excitatory and GABAergic inhibitory neurotransmission resulting in spontaneous seizures in temporal lobe epilepsy (TLE),we systematically monitored extracellular concentrations of GABA1 and later the levels of glutamate and aspartate2 by microdialysis in the ventral hippocampus of rats at various time-points of the disease natural course, i.e., during development and progression of epilepsy. We took advantage of the TLE pilocarpine model in rats, which mimics the disease very accurately in terms of behavioral, electrophysiological and histop....
All experimental procedures have been approved by the University of Ferrara Institutional Animal Care and Use Committee and by the Italian Ministry of Health (authorization: D.M. 246/2012-B) in accordance with guidelines outlined in the European Communities Council Directive of 24 November 1986 (86/609/EEC). This protocol is specifically adjusted for glutamate and aspartate determination in rat brain dialysates obtained under EEG control of microdialysis sessions in epileptic and non-epileptic rats. Many of the materials.......
Probe recovery
The mean recovery (i.e., the mean amino acid content in the perfusate as a percentage of the content in an equal volume of the vial solution) was 15.49 ± 0.42% at a flow rate of 2 μL/min and 6.32 ± 0.64 at 3 μL/min for glutamate and 14.89 ± 0.36% at a flow rate of 2 μL/min and 10.13 ± 0.51 at 3 μL/min for aspartate when using the cuprophane membrane probe. If using the.......
In this work, we show how a continuous video-EEG recording coupled with microdialysis can be performed in an experimental model of TLE. Video-EEG recording techniques are used to correctly diagnose the different phases of the disease progression in animals and the microdialysis technique is used to describe the changes in glutamate release that occur in time (no changes have been found for aspartate in a previously published study2). We strongly recommend the use of a single device/implant to perf.......
The authors wish to thank Anna Binaschi, Paolo Roncon and Eleonora Palma for their contribution to manuscripts published in precedence.
....Name | Company | Catalog Number | Comments |
3-channel two-twisted electrode | Invivo1, Plastic One, Roanoke, Virginia, USA | MS333/3-B/SPC | Material |
guide cannula | Agn Tho's, Lindigö, Sweden | MAB 4.15.IC | Material |
Resin KK2 Plastik | Elettra Sport, Lecco, Italy | KK2 | Material |
Super Attack gel Loctite | Henkel Italia Srl, Milano, Italy | 2047420_71941 | Material |
Imalgene-Ketamine | Merial, Toulouse, France | 221300288 (AIC) | Solution |
Xylazine | Sigma, Milano, Italy | X1251 | Material |
Isoflurane-Vet | Merial, Toulouse, France | 103120022 (AIC) | Solution |
Altadol 50 mg/ ml - tramadol | Formevet, Milano, Italy | 103703017 (AIC) | Solution |
Gentalyn 0.1% crm - gentamycine | MSD Italia, Roma, Italy | 20891077 (AIC) | Material |
simplex rapid dental cement | Kemdent, Associated Dental Products Ltd, Swindon, United Kingdom | ACR811 | Material |
GlasIonomer CX-Plus Cement | Shofu, Kyoto, Japan | PN1167 | Material |
probe clip holder | Agn Tho's, Lindigö, Sweden | p/n 100 5001 | Equipment |
Histoacryl® Blue Topical Skin Adhesive | TissueSeal, Ann Arbor, Michigan, USA | TS1050044FP | Material |
Valium 10 mg/2 ml - diazepam | Roche, Monza, Italy | 019995063 (AIC) | Material |
1 mL syringe with 25G needle | Vetrotecnica, Padova, Italy | 11.3500.05 | Material |
rat flexible feeding needle 17G | Agn Tho's, Lindigö Sweden | 7206 | Material |
Grass Technology apparatus | Grass Technologies, Natus Neurology Incorporated, Pleasanton, California, USA | M665G08 | Equipment (AS40 amplifier, head box, interconnecting cables, telefactor model RPSA S40) |
modular data acquisition and analysis system MP150 | Biopac, Goleta, California, USA | MP150WSW | Equipment |
digital video surveillance system | AverMedia Technologies, Fremont, California, USA | V4.7.0041FD | Equipment |
microdialysis probe | Agn Tho's, Lindigö Sweden | MAB 4.15.1.Cu | Material |
microdialysis probe | Synaptech, Colorado Springs, Colorado, USA | S-8010 | Material |
block heater | Grant Instruments, Cambridge, England | QBD2 | Equipment |
stirrer | Cecchinato A, Aparecchi Scientifici, Mestre, Italy | 711 | Equipment |
infusion pump | Univentor, Zejtun, Malta | 864 | Equipment |
fine bore polythene tubing | Smiths Medical International Ltd., Keene, New Hampshire, USA | 800/100/100/100 | Material |
blue tubing adapters | Agn Tho's, Lindigö Sweden | 1002 | Material |
red tubing adapters | Agn Tho's, Lindigö Sweden | 1003 | Material |
2.5 mL syringe with 22G needle | Chemil, Padova, Italy | S02G22 | Material |
vial cap | Cronus, Labicom, Olomouc, Czech Republic | VCA-1004TB-100 | Material |
septum | Thermo Scientific, Rockwoood, Tennessee, USA | National C4013-60 8 mm TEF/SIL septum | Material |
glass insert with bottom spring | Supelco, Sigma, Milano, Italy | 27400-U | Material |
autosampler vial | National Scientific, Thermo Fisher Scientific, Monza, Italy | C4013-2 | Material |
Smartline manager 5000 system controller and degasser unit | Knauer, Berlin, Germany | V7602 | Equipment |
Smartline 1000 quaternary gradient pump | Knauer, Berlin, Germany | V7603 | Equipment |
spectrofluorometric detector | Shimadzu, Kyoto, Japan | RF-551 | Equipment |
chromatogrphic column | Knauer, Berlin, Germany | 25EK181EBJ | Material |
chromatogrphic pre-column | Knauer, Berlin, Germany | P5DK181EBJ | Material |
mobile phase solution A | 0.1 M sodium phosphate buffer, pH 6.0 | Solution | |
mobile phase solution B | 40% 0.1 M sodium phosphate buffer, 30% methanol, 30% acetonitrile, pH 6.5 | Solution | |
Ringer solution | composition in mM: MgCl2 0.85, KCl 2.7, NaCl 148, CaCl2 1.2, 0.3% BSA | Solution | |
modified Ringer solution | composition in mM: MgCl2 0.85, KCl 100, NaCl 50.7, CaCl2 1.2, 0.3% BSA | Solution | |
saline | 0.9% NaCl, ph adjusted to 7.0 | Solution | |
sucrose solution | 10% sucrose in distilled water | Solution |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved